SCHEMBL2499481

SCHEMBL2499481

COc1ccc(N2CCCCC2)cc1C1(Cl)C(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 5/20 0.45
MMP2 P08253 1/20 0.43
MMP13 P45452 1/20 0.43
ADAM17 P78536 1/20 0.43
ADAMTS5 Q9UNA0 1/20 0.43
ALDH1A1 P00352 4/20 0.43
KCNQ3 O43525 1/20 0.41
KCNQ2 O43526 1/20 0.41
KCNQ4 P56696 1/20 0.41
KCNMA1 Q12791 1/20 0.41
KCNQ5 Q9NR82 1/20 0.41
KDM4E B2RXH2 2/20 0.41
POLB P06746 2/20 0.41
HPGD P15428 2/20 0.41
RAB9A P51151 1/20 0.41
LMNA P02545 3/20 0.40
MAPT P10636 2/20 0.40
ACLY P53396 1/20 0.40
TSHR P16473 1/20 0.40
MEN1 O00255 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2495290 0.89 ALDH1A1 (0.47) HTR7MMP2MMP13ADAM17ADAMTS5
SCHEMBL2492895 0.86 KMT2A (0.44) HTR7MMP2MMP13ADAM17ADAMTS5
SCHEMBL4588923 0.80 ADAMTS5 (0.48) ADAMTS5KCNQ3KCNQ2KCNQ4KCNMA1
SCHEMBL2494490 0.80 KCNMA1 (0.46) MMP2ADAMTS5ALDH1A1KCNQ3KCNQ2
SCHEMBL1795899 0.78 KMT2A (0.51) HTR7MMP2ADAMTS5ALDH1A1KCNQ3
SCHEMBL2493209 0.77 KCNQ3 (0.44) ADAMTS5ALDH1A1KCNQ3KCNQ2KCNQ4
SCHEMBL2495879 0.76 KMT2A (0.46) HTR7MMP2MMP13ADAM17ADAMTS5
SCHEMBL2496619 0.74 KCNQ3 (0.41) HTR7MMP2ADAMTS5ALDH1A1KCNQ3
SCHEMBL4590061 0.74 CBX7 (0.47) HTR7ADAMTS5KCNQ3KCNQ2KCNQ4
SCHEMBL4588940 0.73 CBX7 (0.45) HTR7ADAMTS5KCNQ3KCNQ2KCNQ4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 HTR7 186/4885MMP2 930/4885MMP13 569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.